Drifting With Market
PFE is slipping moderately on low volatility, tracking the S&P 500's broad decline while a positive mid-stage eczema drug result and sector peer moves provide offsetting noise, leaving the stock treading water.
Sources: https://seekingalpha.com/news/pfizer-eczema-drug-succeeds-mid-stage-study, https://247wallst.com/investing/2026/10/01/moderna-climbs-3-desp
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works